Summary
| Direction in Low Back Pain | ↑ Elevated — higher than in the comparison group |
|---|---|
| Category | Other |
| Compared against | control discs |
| Source | Kang et al. 1996 — doi:10.1097/00007632-199602010-00003 |
| Condition atlas | Low Back Pain Biomarker Atlas |
Other conditions where Interleukin-1 beta is reported
- Interleukin-1 beta in Major Depressive Disorder — ↑ elevated vs healthy controls
See the cross-condition hub: Interleukin-1 beta across conditions.
Related Other markers in Low Back Pain
Full list: Low Back Pain Biomarker Atlas.
Frequently asked questions
Is Interleukin-1 beta high or low in Low Back Pain?
Elevated. Studies summarised in the OSMF atlas report higher Interleukin-1 beta in Low Back Pain than in control discs. Source: Kang et al. 1996.
Which test measures Interleukin-1 beta?
The atlas record does not list a standardised clinical test code (LOINC) for Interleukin-1 beta, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.
Is one abnormal Interleukin-1 beta result diagnostic of Low Back Pain?
No. No single biomarker is diagnostic of Low Back Pain. Interleukin-1 beta findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.
Is Interleukin-1 beta specific to Low Back Pain?
No. The same marker is also reported in Major Depressive Disorder in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.
Cite this page
Subscribe on Substack
Last reviewed: 2026-10-08 · Page generated from low-back-pain.json · Browse: Low Back Pain atlas · Biomarker Index · All marker pages
Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.